A detailed history of Tap Consulting, LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Tap Consulting, LLC holds 10,587 shares of CMPS stock, worth $90,412. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,587
Previous 10,587 -0.0%
Holding current value
$90,412
Previous $90,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
N/A
-1,000 Reduced 8.63%
10,587 $90,000
Q4 2023

Feb 02, 2024

SELL
N/A
-1,258 Reduced 9.79%
11,587 $98,000
Q3 2023

Dec 05, 2023

BUY
N/A
1,645 Added 14.69%
12,845 $109,000
Q2 2023

Jul 19, 2023

BUY
$7.79 - $10.69 $87,248 - $119,728
11,200 New
11,200 $95,000
Q1 2022

Apr 26, 2022

SELL
$11.13 - $23.04 $22,260 - $46,080
-2,000 Closed
0 $0
Q4 2021

Jan 27, 2022

BUY
$21.81 - $48.96 $43,620 - $97,920
2,000 New
2,000 $44,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Tap Consulting, LLC Portfolio

Follow Tap Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.